Senator Bill Cassidy, a physician and key G.O.P. vote, joined Democrats in aggressively questioning Robert F. Kennedy Jr., President Trump’s pick for health secretary. He did not say how he would vote ...

Activist short-seller firm Hindenburg Research is calling it quits after an impactful eight-year run in which its reports ... and that he wanted to spend more time with his family and other ...

Rinnerthaler et al. perform a randomized phase 2 trial of neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in patients with early HER2-positive breast cancer and ...

The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market.

A new clinical trial, sponsored by UCL and UCLH, aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile ...

It has been a turbulent time for the pharmaceutical industry ... requiring a shift away from the gold standard randomised ...

Lucknow: The sleeper version of Vande Bharat excelled in its 28-day trial run, supervised by the testing team of Lucknow-based Research Designs and Standards Organisation (RDSO). The prototype ...

A former top official in the breakaway region of Nagorno-Karabakh protested on the eve of his trial before an Azerbaijani military court on Friday that he had not been given enough time to prepare ...

My dad joked his home run ability went down when Preacher Roe signed. They became good friends.” Five days later, Brown homered again, this time off New York Giants pitcher Adrián Zabala in an ...

In a report released today, Jordan Levy from Truist Financial maintained a Hold rating on Sunrun (RUN – Research Report), with a price target of $12.00. The company’s shares closed yesterday ...

RBC Capital analyst Chris Dendrinos maintained a Buy rating on Sunrun (RUN – Research Report) yesterday and set a price target of $17.00. The company’s shares closed yesterday at $9.63.

The new findings are the culmination of more than a decade of research by Raman ... steps we took made this strain at least 100 times safer than anything that’s been tried in the past.” ...